{"id":49072,"date":"2022-10-03T13:02:19","date_gmt":"2022-10-03T11:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/"},"modified":"2022-10-03T13:02:19","modified_gmt":"2022-10-03T11:02:19","slug":"metagenomi-announces-participation-in-october-investor-and-industry-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/","title":{"rendered":"Metagenomi Announces Participation in October Investor and Industry Conferences"},"content":{"rendered":"
\n

EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a gene editing company with a versatile portfolio of next-generation CRISPR gene editing tools, today announced its participation in the following investor and industry conferences:\n<\/p>\n

<\/a><\/p>\n

\nChardan\u2019s 6th Annual Genetic Medicines Conference – New York City
\n
<\/b>Corporate presentation, 9:00 \u2013 9:25 a.m. EDT, followed by a panel presentation on next-generation gene editing, 9:30 \u2013 10:15 a.m. EDT, on October 3
\n
1\u00d71 meetings with institutional investors
\n
Participants: Brian C. Thomas, Ph.D., CEO and founder, and Simon Harnest, CIO, SVP Strategy\n<\/p>\n

\nBMO BioPharma Spotlight Series – Gene Editing & Therapy
\n
<\/b>Panel presentation titled \u201cDiscovery Of Unique Gene Editing Systems And Application In Therapeutics\u201d on October 6, 12:00 p.m. EDT
\n
Participant: Simon Harnest, CIO, SVP Strategy\n<\/p>\n

\nTruist Securities Genetic Medicine Summit
\n
<\/b>October 20
\n
Participant: Simon Harnest, CIO, SVP Strategy\n<\/p>\n

\n5th International Conference on CRISPR Technologies
\n
<\/b>Two scientific presentations, October 31 \u2013 November 2
\n
Participants: Chris Brown, Ph.D., Director of Discovery, and Cindy Castelle, Ph.D., Associate Director, Functional Assay Development & Screening\n<\/p>\n

\nAbout Metagenomi<\/span>\n<\/p>\n

\nMetagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. We adapt and forge these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific and have a decreased risk of immune response. These systems fuel our pipeline of novel medicines and can be leveraged by partners. Our goal is to revolutionize gene editing for the benefit of patients around the world. For more information, please visit https:\/\/metagenomi.co\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>\n<\/p>\n

\nSimon Harnest, CIO, SVP Strategy
\n
simon@metagenomi.co<\/a>
+1 (917) 403-1051\n<\/p>\n

\nMedia Contact:<\/b>\n<\/p>\n

\nAshlye Hodge
\n
ashlye@metagenomi.co<\/a>
+1 (510) 734-4409\n<\/p>\n

\nFollow us on Twitter<\/a> and connect with us on LinkedIn<\/a>.\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a gene editing company with a versatile portfolio of next-generation CRISPR gene editing tools, today announced its participation in the following investor and industry conferences: Chardan\u2019s 6th Annual Genetic Medicines Conference – New York City Corporate presentation, 9:00 \u2013 9:25 a.m. EDT, followed by a panel presentation on next-generation gene editing, 9:30 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49072","6":"format-standard","7":"category-industry"},"yoast_head":"\nMetagenomi Announces Participation in October Investor and Industry Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Metagenomi Announces Participation in October Investor and Industry Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a gene editing company with a versatile portfolio of next-generation CRISPR gene editing tools, today announced its participation in the following investor and industry conferences: Chardan\u2019s 6th Annual Genetic Medicines Conference – New York City Corporate presentation, 9:00 \u2013 9:25 a.m. EDT, followed by a panel presentation on next-generation gene editing, 9:30 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-03T11:02:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221003005279\/en\/1589098\/21\/Metagenomi-logo_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Metagenomi Announces Participation in October Investor and Industry Conferences\",\"datePublished\":\"2022-10-03T11:02:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/\"},\"wordCount\":308,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005279\\\/en\\\/1589098\\\/21\\\/Metagenomi-logo_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/\",\"name\":\"Metagenomi Announces Participation in October Investor and Industry Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005279\\\/en\\\/1589098\\\/21\\\/Metagenomi-logo_RGB.jpg\",\"datePublished\":\"2022-10-03T11:02:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005279\\\/en\\\/1589098\\\/21\\\/Metagenomi-logo_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005279\\\/en\\\/1589098\\\/21\\\/Metagenomi-logo_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Metagenomi Announces Participation in October Investor and Industry Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Metagenomi Announces Participation in October Investor and Industry Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Metagenomi Announces Participation in October Investor and Industry Conferences - Pharma Trend","og_description":"EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a gene editing company with a versatile portfolio of next-generation CRISPR gene editing tools, today announced its participation in the following investor and industry conferences: Chardan\u2019s 6th Annual Genetic Medicines Conference – New York City Corporate presentation, 9:00 \u2013 9:25 a.m. EDT, followed by a panel presentation on next-generation gene editing, 9:30 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-03T11:02:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221003005279\/en\/1589098\/21\/Metagenomi-logo_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Metagenomi Announces Participation in October Investor and Industry Conferences","datePublished":"2022-10-03T11:02:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/"},"wordCount":308,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005279\/en\/1589098\/21\/Metagenomi-logo_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/","url":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/","name":"Metagenomi Announces Participation in October Investor and Industry Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005279\/en\/1589098\/21\/Metagenomi-logo_RGB.jpg","datePublished":"2022-10-03T11:02:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221003005279\/en\/1589098\/21\/Metagenomi-logo_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221003005279\/en\/1589098\/21\/Metagenomi-logo_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/metagenomi-announces-participation-in-october-investor-and-industry-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Metagenomi Announces Participation in October Investor and Industry Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49072"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49072\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}